GB1385652A - Glyceryl 5-aroyl-pyrrole-acetates and propionates and pharmaceutical compositions containing them - Google Patents

Glyceryl 5-aroyl-pyrrole-acetates and propionates and pharmaceutical compositions containing them

Info

Publication number
GB1385652A
GB1385652A GB281673A GB281673A GB1385652A GB 1385652 A GB1385652 A GB 1385652A GB 281673 A GB281673 A GB 281673A GB 281673 A GB281673 A GB 281673A GB 1385652 A GB1385652 A GB 1385652A
Authority
GB
United Kingdom
Prior art keywords
group
pyrrole
alkyl
toluoyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB281673A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
McNeilab Inc
McNeil Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McNeilab Inc, McNeil Laboratories Inc filed Critical McNeilab Inc
Publication of GB1385652A publication Critical patent/GB1385652A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

1385652 Glyceryl - 5 - aroyl - pyrrole - acetates and propionates and pharmaceutical compositions containing them McNEIL LABORATORIES Inc 19 Jan 1973 [21 Jan 1972] 2816/73 Heading C2C The invention comprises compounds of formula wherein Gly represents -CH 2 CH(OH)CH 2 OH; Ar represents a phenyl, thienyl, 5-methylthienyl, mono-, di- or tri-substituted phenyl group, each substituent of said substituted phenyl being a halo, C 1-6 alkyl, -CF 3 , C 1-6 alkoxy, nitro, -NH 2 , -CN or -SCH 3 group; Ar represents a phenyl, mono-, di- or trisubstituted phenyl group, each substituent of said phenyl group being a halo, C 1-6 alkyl, or C 1-6 alkoxy group; R represents H or a C 1-6 alkyl group; R 1 represents a H, C 1-6 alkyl or benzyl group; and R 2 represents H or a C 1-6 alkyl group, provided that: (i) when Ar is a nitro-substituted phenyl or amino-substituted phenyl group, then, with regard to Formula (I-a), R is H and R 1 is a C 1-6 alkyl group; and with regard to Formula (I-e), said R 2 is H; (ii) when Ar is a cyanophenyl group, then R 1 is a C 1-6 alkyl group; and (iii) when R 1 is H, then R is also a hydrogen atom. These compounds may be obtained by heating a compound of formula wherein X is the residual portion of Formulµ I-a, I-b, I-c, I-d or I-e defined above which is attached to the carboxylic function, with an aqueous solution of acetic acid. The following intermediates are referred to: cyanomethyl- 1 - methyl - 5 - (p - toluoyl) - pyrrole - 2 - acetate obtained by the reaction of sodium-1-methyl-5- (p - toluoyl) - pyrrole - 2 - acetate with chloroacetonitrile, in Example I. For similar intermediates see also Example II. 2,2-Dimethyl-1,3- dioxolanylmethyl - 1 - methyl - 5 - (p - toluoyl)- pyrrole-2-acetate is obtained by treating cyanomethyl - 1 - methyl - 5 - (p - toluoyl) - pyrrole- 2-acetate with acetone ketal of glycerine in Example III. For similar intermediates see also Example IV. The invention also comprises a pharmaceutical composition which contains as an active ingredient a compound according to the invention together with a pharmaceutically acceptable inert diluent or carrier.
GB281673A 1972-01-21 1973-01-19 Glyceryl 5-aroyl-pyrrole-acetates and propionates and pharmaceutical compositions containing them Expired GB1385652A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21986572A 1972-01-21 1972-01-21

Publications (1)

Publication Number Publication Date
GB1385652A true GB1385652A (en) 1975-02-26

Family

ID=22821084

Family Applications (1)

Application Number Title Priority Date Filing Date
GB281673A Expired GB1385652A (en) 1972-01-21 1973-01-19 Glyceryl 5-aroyl-pyrrole-acetates and propionates and pharmaceutical compositions containing them

Country Status (9)

Country Link
JP (1) JPS5825671B2 (en)
AT (1) AT323149B (en)
AU (1) AU476415B2 (en)
BE (1) BE794163A (en)
CA (1) CA1016949A (en)
CH (1) CH577965A5 (en)
DE (1) DE2302670A1 (en)
FR (1) FR2183661B1 (en)
GB (1) GB1385652A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62289493A (en) * 1986-06-09 1987-12-16 ヤマハ発動機株式会社 Mounting structure of starting motor for motorcycle

Also Published As

Publication number Publication date
AU5109473A (en) 1974-07-18
DE2302670A1 (en) 1973-07-26
JPS4880554A (en) 1973-10-29
FR2183661B1 (en) 1975-11-21
JPS5825671B2 (en) 1983-05-28
CH577965A5 (en) 1976-07-30
AU476415B2 (en) 1976-09-23
BE794163A (en) 1973-07-17
FR2183661A1 (en) 1973-12-21
CA1016949A (en) 1977-09-06
AT323149B (en) 1975-06-25

Similar Documents

Publication Publication Date Title
GB1100281A (en) New spiro-decane derivatives and process for the preparation thereof
IS1262B6 (en) New composition of content
ES8103072A1 (en) Cephem compounds, processes for their preparation and pharmaceutical compositions containing them.
ES8105001A1 (en) Benzimidazoles, their preparation and pharmaceutical compositions containing them.
IE36017B1 (en) Improvements in or relating to insect control
GB1385652A (en) Glyceryl 5-aroyl-pyrrole-acetates and propionates and pharmaceutical compositions containing them
ES400452A1 (en) Plant growth regulant compositions containing 2-haloethanesulphinic acid compounds
ES446126A1 (en) 2-(phenoxyalkylthio)imidazoles and congeners
IE39344L (en) 7ó-alkoxy cephalosporanates and corresponding¹penicillanates
GB1221713A (en) A method for combating undesirable plant growth
IE39679B1 (en) Methods and compositions for killing parasites of warm blooded animals
GB1028812A (en) Indole derivatives
GB1390866A (en) Cycloalkanoyl-substituted pyrroles and pharmaceutical compo sitions containing them
IE801761L (en) Pharmaceutical compositions
ATE20742T1 (en) PROCESS FOR THE PREPARATION OF PYRAZINE DERIVATIVES.
GB1063572A (en) A process for preparing new triamcinolone esters
IE32946B1 (en) Phenethylamine derivatives and process for the manufacture thereof
ES365965A1 (en) Procedure for the preparation of an antisebooric composition intended to be applied to the scalp. (Machine-translation by Google Translate, not legally binding)
JPS51115402A (en) Process for preparation of alpha-amino acid
GB1438100A (en) Cyclohexane derivatives and their use as odorants
GB1422040A (en) Process for preparing ketones
GB1316665A (en) Substituted 2,4,5-trichloroimidazoles and compositions containing same
IE39626B1 (en) Improvements in or relating to chemical compounds having juvenile hormone activity
GB1105151A (en) New imidazole derivatives, their production and use
ES358795A1 (en) Procedure for the preparation of di-N-oxidos- (1,4) quinovalinas 3-carboxamidas. (Machine-translation by Google Translate, not legally binding)

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee